| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.07 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.08 |